Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels
NCT07360743
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
275
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer (Squamous or Non Squamous)
Interventions
DRUG:
Pembrolizumab
DRUG:
Cemiplimab
Sponsor
UNICANCER